戻る
「早戻しボタン」を押すと検索画面に戻ります。

今後説明を表示しない

[OK]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1  and avoidance of preemptive transfusions of fresh frozen plasma.
2 2,058 nontrauma patients who did not receive fresh frozen plasma.
3 o did receive red blood cells in addition to fresh frozen plasma.
4 ion for patients receiving and not receiving fresh frozen plasma.
5 and nonleukoreduced red cells, platelets, or fresh-frozen plasma.
6 platelets (0.86 U vs. 0.24 U, p = 0.001) and fresh frozen plasma (0.68 U vs. 0.24 U, p = 0.015).
7 ts (0.1 [0.04] vs 1.9 U [4.5] p=0.0001), and fresh-frozen plasma (0.1 [0.07] vs 0.75 U [0.21] p=0.000
8 ut also the proportion of patients requiring fresh frozen plasma (21.1% vs. 48.3%, P = 0.025).
9 s of platelets (10.0 versus 6.6 U, P<0.012), fresh frozen plasma (4.8 versus 3.1 U, P<0.03), and cryo
10 platelets, 12.5 +/- 5.4 U vs. 8.6 +/- 6.4 U; fresh frozen plasma, 9.6 +/- 4.9 U vs. 4.9 +/- 3.6 U; an
11                                  The dose of fresh-frozen plasma administered was highly variable (me
12 ood products (red blood cells, platelets, or fresh frozen plasma) administered during transplantation
13 ulopathy unresponsive to vitamin K requiring fresh-frozen plasma after the first 24 hours postresecti
14 ents who received a total of 46,101 units of fresh frozen plasma and 6,251 units of apheresis platele
15         The relative risk for transfusion of fresh frozen plasma and all infections was 2.99 (2.28-3.
16 ransfusion of high plasma volume components, fresh frozen plasma and apheresis platelets, from potent
17 analysis to evaluate the association between fresh frozen plasma and infectious complication, control
18 gnificant dose-response relationship between fresh frozen plasma and infectious complications (p = .0
19                      The association between fresh frozen plasma and infectious complications remaine
20 ine concentrations, the amount of platelets, fresh frozen plasma and packed erythrocytes used, and th
21 nd anemia were corrected with transfusion of fresh frozen plasma and packed red blood cells.
22 or the continued unbridled administration of fresh frozen plasma and platelets without objective evid
23 ave shown to reduce bleeding, transfusion of fresh frozen plasma and platelets, and possibly mortalit
24 ns to platelets is the highest compared with fresh frozen plasma and red blood cells.
25 association was found between transfusion of fresh frozen plasma and ventilator-associated pneumonia
26 both platelets and coagulant products (e.g., fresh-frozen plasma and recombinant-activated factor VII
27 core analysis adjusting by use of platelets, fresh frozen plasma, and cryoprecipitate; and adjusting
28 h a 68%, 56%, and 58% reduction in platelet, fresh frozen plasma, and packed erythrocyte usage, respe
29 used patients, pooled platelet concentrates, fresh frozen plasma, and packed red cells collected usin
30 ng administration of packed red blood cells, fresh frozen plasma, and platelets in ratios approximati
31 from 7.8% to 92.8% for RBCs, 0% to 97.5% for fresh-frozen plasma, and 0.4% to 90.4% for platelets.
32                C1 inhibitor concentrates and fresh frozen plasma are available for acute intervention
33       Tranexamic acid or virally inactivated fresh frozen plasma can be used for long-term prophylaxi
34         Transfused red cells, platelets, and fresh-frozen plasma can transmit West Nile virus.
35                                 The value of fresh frozen plasma components, both standard and steril
36 use of a combination of packed red cells and fresh-frozen plasma during surgery for congenital heart
37  anticoagulation, and/or plasmapheresis with fresh-frozen plasma exchange, resolved TMA in most patie
38 ns for use of other blood components such as fresh frozen plasma (FFP) and platelet transfusions are
39  sought to define the overall utilization of fresh frozen plasma (FFP) and platelets and the impact o
40 tments utilized in clinical practice include fresh frozen plasma (FFP) and prothrombin complex concen
41 ) and is used to justify preprocedure use of fresh frozen plasma (FFP) and/or platelets (PLT).
42 re in the critically ill, data on the use of fresh frozen plasma (FFP) are limited.
43 duct, human polyclonal antibody, obtained as fresh frozen plasma (FFP) from a HPS survivor.
44 from Iraq supporting early aggressive use of fresh frozen plasma (FFP) in a 1:1 ratio to packed red b
45  plasma volume was removed and replaced with fresh frozen plasma (FFP) or with 50% FFP and 50% albumi
46                Because the administration of fresh frozen plasma (FFP) prevents gastrointestinal blee
47  The practice of a high transfusion ratio of fresh frozen plasma (FFP) to red blood cells (RBCs) has
48       We assessed the safety and efficacy of fresh frozen plasma (FFP) versus prothrombin complex con
49 amounts of packed red blood cells (RBCs) and fresh frozen plasma (FFP) were recorded during hospital
50 ross as a virally inactivated alternative to fresh-frozen plasma (FFP).
51 8 U blood products (red blood cells [RBCs] + fresh frozen plasma [FFP] + platelets) had a median (int
52 otal of 380 non-trauma patients who received fresh frozen plasma from 2004 to 2005 were compared with
53 ciation between infection and transfusion of fresh frozen plasma in patients who did not receive conc
54 e vWf-cleaving metalloprotease is present in fresh-frozen plasma, in cryoprecipitate-depleted plasma
55               The severe group required more fresh-frozen plasma intraoperatively than the mild group
56                               Transfusion of fresh frozen plasma is associated with an increased risk
57 cation of these patients is critical so that fresh frozen plasma may be avoided.
58 o >1.5) or clinical (transfusion >2 units of fresh frozen plasma or >1 pack of platelets in 6 hours)
59  six allografts lost, despite treatment with fresh-frozen plasma or plasmapheresis.
60  red blood cells, platelet concentrates, and fresh frozen plasma over the routine storage time.
61 ion of packed red blood cells (p = .442) and fresh frozen plasma (p = .063) were not different betwee
62 ess was developed to inactivate pathogens in fresh frozen plasma (PCT-FFP).
63 ive bleeding disorder treated by infusion of fresh-frozen plasma, plasma-derived FVII concentrates an
64 re frequent recurrences, and prescription of fresh-frozen plasma prophylaxis.
65   The administration of coagulation factors (fresh frozen plasma, prothrombin complex concentrates or
66           The mean packed red blood cells to fresh frozen plasma ratio changed from 2.6:1 during the
67                                       Higher fresh frozen plasma ratios (> 1:2) were not associated w
68 use of a combination of packed red cells and fresh-frozen plasma (reconstituted blood) for priming of
69 r bias improved survival outcome with higher fresh frozen plasma: red blood cell ratios.
70 ction without prior PVE demonstrated a lower fresh frozen plasma requirement (P = 0.01), a lower peak
71 VE than the PVE group, as were postoperative fresh-frozen plasma requirements.
72 95% confidence interval [CI], 0.57 to 0.99), fresh frozen plasma (RR, 0.37; 95% CI, 0.21 to 0.64), an
73                                              Fresh-frozen plasma should be given for documented defic
74 ontinued, and treatment with plasmapheresis, fresh frozen plasma, steroids, and OKT3 was begun.
75 ence of reactions to platelets compared with fresh frozen plasma suggests that a platelet-related fac
76                                              Fresh frozen plasma-to-packed RBCs and platelets-to-pack
77             The benefits of higher ratios of fresh frozen plasma-to-packed RBCs and platelets-to-pack
78  with an odds ratio of infection per unit of fresh frozen plasma transfused equal to 1.039 (1.013-1.0
79 -test allowed comparison of average units of fresh frozen plasma transfused to patients with and with
80 rative packed red cells (r=0.28, P=.049) and fresh frozen plasma transfusions (r=0.42, P=.004), highe
81 nternational normalized ratios, 33% received fresh-frozen plasma transfusions during their intensive
82                            Wide variation in fresh-frozen plasma treatment exists suggesting clinical
83                         Fifty-one percent of fresh-frozen plasma treatments were to nonbleeding patie
84  of platelet units (4.3 vs. 1.7, p =.05) and fresh frozen plasma units (1.1 vs. 0.6, p =.08) also was
85  tests) and the transfusion (blood units and fresh frozen plasma units) during the operative period w
86 id infusion volume (6.1-3.2 L) and increased fresh frozen plasma use (3.2-10.1 U) (both P < .05) in t
87 apy and treatment with lactulose, vitamin K, fresh frozen plasma, ventilatory assistance, and intensi
88 unoglobulin (4 cases), interferon (3 cases), fresh frozen plasma with WNV IgG (2 cases), and ribaviri

WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。